← Leaderboards
Keykavous Parang
University Of Rhode Island
$446,971
Attributed
$919,168
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $415.5K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$919,168 · 4
By mechanism
R15$415,500 · 1
R43$352,596 · 1
P20$151,072 · 2
Top collaborators
- Elizabeth Garcia1 shared
- John Marshall1 shared
- Angela L Slitt1 shared
- Sun Yang1 shared
Others in their field
Top investigators on “Organ”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lawrence Corey · Fred Hutchinson Cancer Center$451,040,128
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
OrganBiological AvailabilityDrug KineticsNovel StrategiesPathway InteractionsHeartCell SurvivalDoseInnovationMalignant NeoplasmsPharmaceutical PreparationsToxic EffectIn VivoIn VitroCell DeathCellsCyclic PeptidesDesignArginineAreaAnalogApoptosisBrainAntineoplastic Agents
Grant awards (4)
Peptide-Doxorubicin Conjugates for Mitigating Cardiotoxicity and Overcoming Drug Resistance in Cancer$415,500
R15 · FY2025 · CA · contact PI
Treatment of stroke using a novel PDZ binding peptidomimetic drug.$352,596
R43 · FY2011 · NS
MECHANISTIC STUDIES OF PROTEIN TYROSINE KINASE ACTIVATION BY ARSENITE$100,081
P20 · FY2005 · RR
DESIGN AND SYNTHESIS OF PEPTIDE ANALOGS AS INHIBITORS OF SRC TYROSINE KINASES$50,991
P20 · FY2004 · RR